Amc Is Now Back At Martin Shkreli S Fair Value Estimate For The Stock As Ape Shares Debut Unleashes A Sell The News Type Of Move
The disgraced former pharma executive, Martin Shkreli, had antagonized AMC (NYSE: AMC) apes last month by publishing his bearish thesis on the stock, pegging an $11 price target on the theater chain’s shares. Since then, AMC shares surged nearly 100 percent to hit a recent high of over $25, only to give back all of these nascent gains as the meme stock mania 2.0 fizzled out, helped along by the implosion in Bed Bath & Beyond shares as well as the utter carnage that was the recent German PPI print, which hammered home the likelihood of structurally elevated inflation across the developed world for the foreseeable future....